Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats

[1] Kanda T(2014)High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material Radiology 270 834-841

[2] Ishii K(2014)Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation Investig Radiol 49 685-690

[3] Kawaguchi H(2015)High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration Radiology 275 803-809

[4] Kitajima K(2015)Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent Radiology 275 783-791

[5] Takenaka D(2015)Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration Investig Radiol 50 743-748

[6] Errante Y(2017)No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents Radiology 282 699-707

[7] Cirimele V(2008)Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C Investig Radiol 43 817-828

[8] Mallio CA(2015)T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats: difference between linear and macrocyclic agents Investig Radiol 50 473-480

[9] Di Lazzaro V(2016)Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents: comparison of linear and macrocyclic agents Investig Radiol 51 83-89

[10] Zobel BB(2016)Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats Investig Radiol 51 73-82

[1] Kanda T(2014)High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material Radiology 270 834-841

[2] Ishii K(2014)Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation Investig Radiol 49 685-690

[3] Kawaguchi H(2015)High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration Radiology 275 803-809

[4] Kitajima K(2015)Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent Radiology 275 783-791

[5] Takenaka D(2015)Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration Investig Radiol 50 743-748

[6] Errante Y(2017)No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents Radiology 282 699-707

[7] Cirimele V(2008)Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C Investig Radiol 43 817-828

[8] Mallio CA(2015)T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats: difference between linear and macrocyclic agents Investig Radiol 50 473-480

[9] Di Lazzaro V(2016)Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents: comparison of linear and macrocyclic agents Investig Radiol 51 83-89

[10] Zobel BB(2016)Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats Investig Radiol 51 73-82